Bloch E F, Schmetz M A, Foulds J, Hammer C H, Frank M M, Joiner K A
J Immunol. 1987 Feb 1;138(3):842-8.
We have shown recently that an average of three or more C9 molecules must bind to C5b-8 on Escherichia coli strain J5 to cause direct complement killing in the absence of serum lysozyme. We initially confirmed and extended this observation by showing that deposition of a large number of C5b-9 complexes bearing 1C9 per C5b-8 was not bactericidal for J5. To identify the target site for bactericidal C5b-9 deposition, we measured release of periplasmic and cytoplasmic markers of different size from J5 as the C9:C5b-8 ratio was changed, because the diameter of the C5b-9 channel is known to increase as the C9:C5b-8 ratio increases. To facilitate measurement of release of the periplasmic marker beta-lactamase (BLA), J5 was transformed for high level constitutive TEM-1 BLA production (J5-Amp). Multimeric C9 within C5b-9 (C9:C5b-8 greater than 3) was required to release BLA (m.w. 28,900) from J5-Amp regardless of whether cells bore 310, 560, or 890 C5b-9/organism. Curves of both BLA release and killing vs C9:C5b-8 ratio were sigmoidal and nearly superimposable. Release of the small cytoplasmic marker 86Rb, a potassium analog, also required a minimum C9:C5b-8 ratio of 3:1; specific 86Rb release did not occur in the absence of killing. Release of the large cytoplasmic marker beta-galactosidase (m.w. 505,000) did not occur even at the highest achievable C9:C5b-8 ratio of 11:1, despite greater than 99.9% killing, indicating that there was no dissolution of the peptidoglycan layer due to incomplete removal of serum lysozyme. Complement-mediated killing of J5 requires sufficient damage to the outer membrane or formation of a sufficiently large C5b-9 channel to release the large periplasmic marker BLA. The requirement of multimeric C9 for 86Rb release suggests that at low C9:C5b-8 ratios, either C5b-9 does not have access to the cytoplasmic space or that the J5 K+ transport systems are able to compensate for putative C5b-9 channels.
我们最近发现,在没有血清溶菌酶的情况下,平均三个或更多的C9分子必须与大肠杆菌J5菌株上的C5b-8结合,才能引起补体直接杀伤作用。我们最初通过证明大量每个C5b-8带有1个C9的C5b-9复合物的沉积对J5没有杀菌作用,来证实并扩展了这一观察结果。为了确定杀菌性C5b-9沉积的靶位点,我们在改变C9:C5b-8比例时,测量了J5中不同大小的周质和细胞质标志物的释放,因为已知C5b-9通道的直径会随着C9:C5b-8比例的增加而增大。为了便于测量周质标志物β-内酰胺酶(BLA)的释放,将J5进行转化以实现高水平组成型TEM-1 BLA的产生(J5-Amp)。无论细胞携带310、560还是890个C5b-9/菌体,C5b-9中的多聚体C9(C9:C5b-8大于3)都是从J5-Amp释放BLA(分子量28,900)所必需的。BLA释放曲线和杀伤曲线与C9:C5b-8比例均呈S形且几乎重叠。小的细胞质标志物86Rb(一种钾类似物)的释放也需要最小C9:C5b-8比例为3:1;在没有杀伤作用时不会发生特异性86Rb释放。即使在可达到的最高C9:C5b-8比例11:1时,大的细胞质标志物β-半乳糖苷酶(分子量505,000)也没有释放,尽管杀伤率大于99.9%,这表明由于血清溶菌酶未被完全清除,肽聚糖层没有溶解。补体介导的J5杀伤需要对外膜造成足够的损伤或形成足够大的C5b-9通道以释放大的周质标志物BLA。86Rb释放需要多聚体C9,这表明在低C9:C5b-8比例下,要么C5b-9无法进入细胞质空间,要么J5的钾离子转运系统能够补偿假定的C5b-9通道。